Previous close | 0.8600 |
Open | 0.9600 |
Bid | 1.1500 |
Ask | 1.2000 |
Strike | 27.00 |
Expiry date | 2024-05-10 |
Day's range | 0.9600 - 1.2500 |
Contract range | N/A |
Volume | |
Open interest | 44.88k |
Andrew Baum, the prominent Wall Street drug company analyst will be the pharma firm’s chief strategy and innovation officer.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The pharmaceutical company posts a first-quarter loss of €1.31 a share, a swing from year-earlier profit of €2.05.